Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Hemab ApS
APS
Active
CVR 40837590
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 6 years old
34 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Hemab ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-50M
-101M
-151M
-201M
-10M
2020
-41M
-310%
2021
-161M
-293%
2022
-27M
+83%
2023
-48M
-78%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
—
—
—
—
Staff expenses
-180
-0
-17.655
-4.316
-10.663
EBITDA
-10.256
-41.156
-161.480
-27.069
-47.897
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-10.256
-41.156
-161.480
-27.069
-47.897
Net financials
-294
1.023
224
5.081
270
Profit before tax
-10.550
-40.134
-161.256
-21.988
-47.627
Tax
-2.410
-4.971
-4.849
795
585
Net profit
-8.139
-35.163
-156.407
-22.783
-48.212
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
14.496
78.696
32.916
139.476
96.902
Equity
10.532
68.035
6.101
136.196
88.354
Long-term debt
3.353
0
0
167
1.974
Short-term debt
611
10.661
26.815
3.113
6.574
Total debt
3.964
10.661
26.815
3.280
8.548
Financial ratios
5-year trend
EBITDA margin
-4789700000.0%
This company
15.8%
Market median
-30314557062% vs market
2020
2024
Equity ratio
91.2%
This company
38.2%
Market median
+139% vs market
2020
2024
Return on equity
-54.6%
This company
18.4%
Market median
-397% vs market
2020
2024
Net profit margin
-4821200000.0%
This company
8.1%
Market median
-59520987754% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-09-27 – 2020-12-31
View
PDF
More on Hemab ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
